Download the full event guide to see what was explored in 2024 including examining the technical and strategical developments in the discovery, validation and clinical progression of single agent and combination therapies shaking-up the precision oncology landscape. Along with the development of next generation inhibitors, explore the development of novel RAS-targeting PROTACs, molecular glues, cell therapies and vaccines boasting improved depth and durability of response as they seek for best-in-class.